Skip to main content
SpringerLink
Log in
Book cover

Pre-Menopause, Menopause and Beyond pp 141–152Cite as

Metabolic Changes and Metabolic Syndrome During the Menopausal Transition

  • Chapter
  • First Online:

Part of the book series: ISGE Series ((ISGE))

Abstract

Please check the hierarchy of the section headings and confirm if correct.

This is a preview of subscription content, log in via an institution.

References

  1. Innes KE, Selfe TK, Taylor AG (2008) Menopause, the metabolic syndrome and mind-body therapies. Menopause 15:1005–1013

    Article  PubMed  PubMed Central  Google Scholar 

  2. Baker L, Meldrum KK, Wang M et al (2003) The role of estrogen in cardiovascular disease. J Surg Res 115:325–344

    Article  CAS  PubMed  Google Scholar 

  3. Spencer CP, Godsland IF, Stevenson JC (1997) Is there a menopausal metabolic syndrome? Gynecol Endocrinol 11:341–355

    Article  CAS  PubMed  Google Scholar 

  4. Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404–2411

    Article  CAS  PubMed  Google Scholar 

  5. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET (2002) Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 77:128–135

    Article  PubMed  Google Scholar 

  6. Kawano H, Yasue H, Hirai N, Yoshida T, Fukushima H, Miyamoto S, Kojima S, Hokamaki J, Nakamura H, Yodoi J, Ogawa H (2003) Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state. Int J Clin Pharmacol Ther 41:346–353

    Article  CAS  PubMed  Google Scholar 

  7. Ross LA, Polotsky AJ (2012) Metabolic correlates of menopause: an update. Curr Opin Obstet Gynecol 24:402–407

    Article  PubMed  Google Scholar 

  8. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241

    Article  CAS  PubMed  Google Scholar 

  9. Genazzani AD, Vito G, Lanzoni C, Strucchi C, Mehmeti H, Ricchieri F, Mbusnum MN (2005) La Sindrome Metabolica menopausale. Giorn It Ost Gin 11/12:487–493

    Google Scholar 

  10. Ibrahim M (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11–18

    Article  PubMed  Google Scholar 

  11. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM (2007) International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116(17):1942–1951

    Article  PubMed  PubMed Central  Google Scholar 

  12. Carmina E (2013) Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. Front Horm Res 40:40–50

    Article  CAS  PubMed  Google Scholar 

  13. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P (2012) Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric 15(5):419–429

    Article  CAS  PubMed  Google Scholar 

  14. Lovejoy JC, Champagne CM, De Longe L, Xie H, Smith SR (2008) Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 32(6):949–958

    Article  CAS  Google Scholar 

  15. Cagnacci A, Volpe A, Paoletti AM, Melis GB (1997) Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril 68(3):421

    Article  CAS  PubMed  Google Scholar 

  16. Webb P (1986) 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr 44:14

    Article  Google Scholar 

  17. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, DeSimone L, Genazzani AR (1999) Climacteric modifications in body weight and fat tissue distribution. Climateric 2(1):37–44

    Article  CAS  Google Scholar 

  18. Roubenoff R, Hughes VA, Dallal GE, Nelson ME, Morganti C, Kehayias JJ, Singh MA, Roberts S (2000) The effect of gender and body composition method on the apparent decline in lean mass-adjusted resting metabolic rate with age. J Gerontol A Biol Sci Med Sci 55(12):M757–M760

    Article  CAS  PubMed  Google Scholar 

  19. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, Boyce V, Howard BV, Bogardus C (1988) Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318(8):467–472

    Article  CAS  PubMed  Google Scholar 

  20. Veldhuis JD, Bowers CY (2003) Sex-steroid modulation of growth hormone (GH) secretory control: three-peptide ensemble regulation under dual feedback restraint by GH and IGF-I. Endocrine 22(1):25–40

    Article  CAS  PubMed  Google Scholar 

  21. Walenkamp JD, Wit JM (2006) Genetic disorders in the growth hormone-insulin-like growth factor-I axis. Horm Res 66(5):221–230

    CAS  PubMed  Google Scholar 

  22. Peppa M, Koliacki C, Dimitriadis G (2012) Body composition as an important determinant of metabolic syndrome in postmenopausal women. Endocrinol Metabol Syndr 2:1. doi:10.4172/2161-1017.S1-009

    Article  Google Scholar 

  23. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U (1983) Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 72:1150–1162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. D’Eont M, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS (2005) Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280:35983–35991

    Article  Google Scholar 

  25. Messina G, Viggiano A, DeLuca V, Messina A, Chieffi S, Monda M (2013) Hormonal changes in menopause and Orexin-A action. Obst Gynecol Int 2013:1–5

    Article  Google Scholar 

  26. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Ann Rev Neurosci 24:429–458

    Article  CAS  PubMed  Google Scholar 

  27. Kukkonen JP, Holmqvist T, Ammoun S, Akerman KEO (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol 283(6):C1567–C1591

    Article  CAS  Google Scholar 

  28. El-Sedeek M, Korish AA, Deef MM (2010) Plasma orexin-A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status. BJOG 117(4):488–492

    Article  CAS  PubMed  Google Scholar 

  29. Genazzani AD, Ricchieri F, Lanzoni C (2010) Use of metformin in the treatment of polycystic ovary syndrome. Womens Health 6(4):577–593

    CAS  Google Scholar 

  30. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142(3):269–273

    Article  CAS  PubMed  Google Scholar 

  31. Genazzani D, Chierchia E, Rattighieri E, Santagni S, Casarosa E, Luisi M, Genazzani AR (2010) Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol 26(9):684–689

    Article  CAS  PubMed  Google Scholar 

  32. Kerchner A, Lester W, Stuart SP, Dokras A (2009) Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 91:207–212

    Article  PubMed  Google Scholar 

  33. Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR (2006) Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol 22(1):36–43

    Article  CAS  PubMed  Google Scholar 

  34. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM (2008) Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 24(3):139–144

    Article  CAS  PubMed  Google Scholar 

  35. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, Tapanainen JS (2011) Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab 96(6):1827–1834

    Article  CAS  PubMed  Google Scholar 

  36. Roussel M, Garnier S, Lemoine S, Gaubert I, Charbonnier L, Auneau G, Mauriège P (2009) Influence of a walking program on the metabolic risk profile of obese postmenopausal women. Menopause 16(3):566–575

    Article  PubMed  Google Scholar 

  37. Martins C, Kulseng B, King NA, Holst JJ, Blundell JE (2010) The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab 95:1609–1616

    Article  CAS  PubMed  Google Scholar 

  38. Genazzani AR, Gambacciani M (2006) Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 22(3):145–150

    Article  CAS  PubMed  Google Scholar 

  39. Tommaselli GA, DiCarlo C, Di Spiezio SA, Bifulco CG, Cirillo D, Guida M, Papasso R, Nappi C (2006) Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 13:660–668

    Article  PubMed  Google Scholar 

  40. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C (2004) Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 11:466–473

    Article  PubMed  Google Scholar 

  41. Meli R, Pacilio M, Mattace Raso G, Esposito E, Coppola A, Nasti A, Di Carlo C, Nappi C, Di Carlo C (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145:3115–3121

    Article  CAS  PubMed  Google Scholar 

  42. Sammel MD, Freeman EW, Liu Z, Lin H, Guo W (2009) Factors that influence entry into stages of the menopausal transition. Menopause 16(6):1218–1227

    Article  PubMed  PubMed Central  Google Scholar 

  43. dos Reis CM, de Melo NR, Meirelles ES, Vezozzo DP, Halpern A (2003) Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas 46:59–68

    Article  PubMed  Google Scholar 

  44. Morris DH, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ (2012) Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the Breakthrough Generations Study. Am J Epidemiol 175:998–1005

    Article  PubMed  Google Scholar 

  45. Krents AJ, von Muhlen D, Barret-Connor E (2012) Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study. Metabolism 61:1238–1241

    Article  Google Scholar 

  46. Sowers MR, Randolph JF, Zheng H et al (2011) Genetic polymorphisms and obesity infl uence estradiol decline during the menopause. Clin Endocrinol 74:618–623

    Article  CAS  Google Scholar 

  47. Jones GL, Sutton A (2008) Quality of life in obese postmenopausal women. Menopause Int 14:26–32

    CAS  PubMed  Google Scholar 

  48. Nappi RE, Verde JB, Polatti F, Genazzani AR, Zara C (2002) Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Investig 53:181–187

    Article  Google Scholar 

  49. Llaneza P, Gonzalez C, Fernandez-Inarrea J, Alonso A, Arnott I, Ferrer-Barriendos J (2009) Insulin resistance and health-related quality of life in postmenopausal women. Fertil Steril 91(Suppl 4):1370–1373

    Article  PubMed  Google Scholar 

  50. Sowers MR, Zheng H, Jannausch ML, McConnell D, Nan B, Harlow S, Randolph JF Jr (2010) Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 95:2155–2162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Van der Voort DJ, Geusens PP, Dinant GJ (2001) Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int 12:630–638

    Article  PubMed  Google Scholar 

  52. Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Díez-Pérez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES, Investigators G (2011) Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 124:1043–1050

    Article  PubMed  PubMed Central  Google Scholar 

  53. Poehlman E, Toth MJ, Gardner A (1995) Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123:673–678

    Article  CAS  PubMed  Google Scholar 

  54. Douketis JD, Macie C, Thabane L, Williamson DF (2005) Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes 29:1153–1167

    Article  CAS  Google Scholar 

  55. Freedman MR, King J, Kennedy E (2001) Popular diets: a scientific review. Obes Rev 9(Suppl 1):1–40S

    Google Scholar 

  56. National Institute for Health and Clinical Excellence (2006) Clinical guideline CG43. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children, London. http://guidance.nice.org.uk/CG43/NICEGuidance/pdf/English

  57. Ioannides-Demos LL, Piccenna L, McNeil JJ (2011) Pharmacotherapies for obesity: past, current, and future therapies. J Obes 2011:179674

    Article  PubMed  Google Scholar 

  58. Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM (2007) Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol 23:146–152

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Gynecological Endocrinology Center, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100, Modena, Italy

    Alessandro D. Genazzani, Alessia Prati & Giulia Despini

Authors
  1. Alessandro D. Genazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessia Prati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia Despini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro D. Genazzani .

Editor information

Editors and Affiliations

  1. Professor emeritus for Gynaecological Endocrinology and Reproductive Medicine, University of Bern, Bern, Switzerland

    Martin Birkhaeuser

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2018 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Genazzani, A.D., Prati, A., Despini, G. (2018). Metabolic Changes and Metabolic Syndrome During the Menopausal Transition. In: Birkhaeuser, M., Genazzani, A. (eds) Pre-Menopause, Menopause and Beyond. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-63540-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63540-8_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63539-2

  • Online ISBN: 978-3-319-63540-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation